Bruker Corporation (BRKR)

Market Cap	10.67B
Revenue (ttm)	2.53B
Net Income (ttm)	296.60M
Shares Out	146.73M
EPS (ttm)	1.99
PE Ratio	36.55
Forward PE	26.11
Dividend	$0.20 (0.28%)
Ex-Dividend Date	Feb 28, 2023

Volume	677,436
Open	72.69
Previous Close	72.18
Day's Range	72.00 - 73.42
52-Week Range	48.42 - 76.81
Beta	1.14
Analysts	Buy
Price Target	81.03 (+11.4%)
Earnings Date	May 3, 2023

About BRKR

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 4, 2000
• Employees: 7,765
• Stock Exchange: NASDAQ
• Ticker Symbol: BRKR

Financial Performance

In 2022, Bruker's revenue was $2.53 billion, an increase of 4.67% compared to the previous year's $2.42 billion. Earnings were $296.60 million, an increase of 7.04%.

Analyst Forecast

According to 17 analysts, the average rating for BRKR stock is "Buy." The 12-month stock price forecast is $81.03, which is an increase of 11.40% from the latest price.

Price Target

$81.03

(11.40% upside)

Analyst Consensus: Buy